Amphastar

Showing 1 posts of 1 posts found.

naloxone

FDA rejects Amphastar’s application for NDA for intranasal overdose treatment

February 21, 2017
Research and Development Amphastar, FDA

Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …

Latest content